SEC SCHEDULE 13G

Company

IMMUCELL CORP /DE/

Filed

January 29, 2020

Accession Number

0000846087-20-000016

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →